Background. Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) induce effector memory T-cell expansions, which are variable and potentially depend on the age at primary exposure and coinfections. We evaluated the T-cell compartment and herpesvirus infections in 6-year-old children. Methods. T-cell subsets and immunoglobulin G seropositivity for CMV, EBV, herpes-simplex virus 1, and varicella-zoster virus were studied in 1079 6-year-old children. A random subgroup of 225 children was evaluated for CMV and EBV seropositivity before 2 years of age and for vaccination responses against measles and tetanus. Results. CMV and EBV infections were associated with significant expansions of CD27- and CD27+ effector memory T cells, respectively. These expansions were enhanced in CMV-EBV-coinfected children and were independent of varicella-zoster virus or herpes-simplex virus 1 coinfection. Naive and central memory T-cell numbers were not affected, nor were anti-tetanus and anti-measles immunoglobulin G levels. Children infected before 2 years of age showed smaller effector memory T-cell expansions than those infected between 2 and 6 years of age. Conclusions. CMV- and EBV-related T-cell expansions do not impair naive T-cell numbers or maintenance of protective responses against nonrelated pathogens. Duration of infection was not directly related to larger expansions of effector memory T cells in children, suggesting that other mechanisms affect these expansions at later age.

childhood adaptive immune system, cytomegalovirus (CMV), effector memory T-cell expansions, Epstein-Barr virus (EBV), herpes-simplex virus 1 (HSV-1), persistent herpesvirus infection, T-cell compartment, varicella-zoster virus (VZV)
dx.doi.org/10.1093/infdis/jiv369, hdl.handle.net/1765/86341
The Journal of Infectious Diseases
Department of Immunology

Van Den Heuvel, D, Jansen, M.A.E, Dik, W.A, Bouallouch-Charif, H, Zhao, D, Van Kester, K.A.M, … van Zelm, M.C. (2016). Cytomegalovirus- and epstein-barr virus-induced T-cell expansions in young children do not impair naive T-cell populations or vaccination responses: The Generation R study. The Journal of Infectious Diseases, 213(2), 233–242. doi:10.1093/infdis/jiv369